Clinical Trial Update: Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating interleukin-1 blockade for fatigue in primary Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Snippet

Sponsor: Helse Stavanger HF | Conditions: Fatigue, Primary Sjogren | Phase 2 | Status: COMPLETED